FI952805A - Asetosalisyylihappoa sisältävä transdermaalinen vapautumisjärjestelmä antitromboottiseen terapiaan ja syövän ennaltaehkäisyyn - Google Patents

Asetosalisyylihappoa sisältävä transdermaalinen vapautumisjärjestelmä antitromboottiseen terapiaan ja syövän ennaltaehkäisyyn Download PDF

Info

Publication number
FI952805A
FI952805A FI952805A FI952805A FI952805A FI 952805 A FI952805 A FI 952805A FI 952805 A FI952805 A FI 952805A FI 952805 A FI952805 A FI 952805A FI 952805 A FI952805 A FI 952805A
Authority
FI
Finland
Prior art keywords
delivery system
transdermal delivery
cancer prevention
antithrombotic therapy
acetosalicylic acid
Prior art date
Application number
FI952805A
Other languages
English (en)
Swedish (sv)
Other versions
FI952805A0 (fi
FI120719B (fi
Inventor
Frank Becher
Thomas Kissel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4241128A external-priority patent/DE4241128C2/de
Priority claimed from PCT/EP1993/003231 external-priority patent/WO1994013302A1/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI952805A0 publication Critical patent/FI952805A0/fi
Publication of FI952805A publication Critical patent/FI952805A/fi
Application granted granted Critical
Publication of FI120719B publication Critical patent/FI120719B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI952805A 1992-12-07 1995-06-07 Menetelmä asetyylisalisyylihappoa sisältävän transdermaalisen järjestelmän valmistamiseksi FI120719B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4241128A DE4241128C2 (de) 1991-12-20 1992-12-07 Verwendung eines transdermalen Verabreichungssystems, das als Wirkstoff Acetylsalicylsäure und/oder pharmazeutisch akzeptable Salze davon enthält
DE4241128 1992-12-07
EP9303231 1993-11-18
PCT/EP1993/003231 WO1994013302A1 (de) 1991-12-20 1993-11-18 Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe

Publications (3)

Publication Number Publication Date
FI952805A0 FI952805A0 (fi) 1995-06-07
FI952805A true FI952805A (fi) 1995-06-07
FI120719B FI120719B (fi) 2010-02-15

Family

ID=6474576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952805A FI120719B (fi) 1992-12-07 1995-06-07 Menetelmä asetyylisalisyylihappoa sisältävän transdermaalisen järjestelmän valmistamiseksi

Country Status (14)

Country Link
EP (1) EP0671916A1 (fi)
JP (1) JP3799502B2 (fi)
AU (1) AU694410B2 (fi)
CA (1) CA2150033A1 (fi)
CZ (1) CZ149495A3 (fi)
FI (1) FI120719B (fi)
HR (1) HRP931474A2 (fi)
HU (1) HUT75680A (fi)
IL (1) IL107867A (fi)
NO (1) NO952234D0 (fi)
NZ (1) NZ258129A (fi)
PL (1) PL174770B1 (fi)
SK (1) SK75495A3 (fi)
ZA (1) ZA939126B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1738623A (zh) * 2003-01-23 2006-02-22 夏尔控股公司 治疗血小板增多症的制剂和方法
EP1716854A4 (en) 2004-02-16 2010-01-20 Teikoku Seiyaku Kk EXTERNAL PREPARATION FOR TREATING PAINFUL SKIN WOUNDS
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
JP6720257B2 (ja) * 2018-09-05 2020-07-08 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy

Also Published As

Publication number Publication date
CA2150033A1 (en) 1994-06-23
FI952805A0 (fi) 1995-06-07
IL107867A0 (en) 1994-04-12
AU5563294A (en) 1994-07-04
NO952234L (no) 1995-06-06
NO952234D0 (no) 1995-06-06
PL309285A1 (en) 1995-10-02
NZ258129A (en) 1999-10-28
AU694410B2 (en) 1998-07-23
HU9501641D0 (en) 1995-08-28
EP0671916A1 (de) 1995-09-20
HUT75680A (en) 1997-05-28
SK75495A3 (en) 1996-05-08
ZA939126B (en) 1994-08-05
FI120719B (fi) 2010-02-15
PL174770B1 (pl) 1998-09-30
JP3799502B2 (ja) 2006-07-19
CZ149495A3 (en) 1996-03-13
IL107867A (en) 1998-08-16
JPH08504198A (ja) 1996-05-07
HRP931474A2 (en) 1994-12-31

Similar Documents

Publication Publication Date Title
GB2163347B (en) Transdermal drug delivery system
AU5167993A (en) Failsafe iontophoresis drug delivery system
AU4370593A (en) Tissue-specific implantable therapeutic agent delivery system
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
EP0237263A3 (en) Transdermal drug delivery system
DE59209886D1 (de) Implantierbares Defibrillationssystem
DE69313510D1 (de) Abgabekatheter
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
AU2816589A (en) Self-regulated therapeutic agent delivery system and method
DE59308186D1 (de) Implantierbares defibrillationssystem
EP0707471A4 (en) NEW ADMINISTRATION SYSTEMS FOR ACTIVE SUBSTANCES
EP0654973A4 (en) LYPHATIC TISSUE DRUG ADMINISTRATION SYSTEM.
DE59307855D1 (de) Defibrillierungssystem
CA2117891A1 (en) Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
FI942922A0 (fi) Asetyylisalisyylihappoa sisältävä ihon läpi tapahtuva antojärjestelmä antitromboottiseen terapiaan ja syövän ehkäisyyn
DK19893D0 (da) Praeparat til nasal behandling
EP0746292A4 (en) TRANSDERMAL MEDICINE SUPPLY USING MONOAKYLPHOSPHATES AND OTHER ABSORPTION AMPLIFIERS
AU6226894A (en) Implantable therapy systems and methods
KR950700707A (ko) 치과용 치료시스템
DE69214558D1 (de) Krebstherapiesystem
EP0729370A4 (en) DEVICE AND METHOD FOR IONTOPHORETIC ADMINISTRATION OF MEDICINES
NO973292D0 (no) On-line medikamentleveringssystem i ekstrakorporeal terapi
FI952805A0 (fi) Asetosalisyylihappoa sisältävä transdermaalinen vapautumisjärjestelmä antitromboottiseen terapiaan ja syövän ennaltaehkäisyyn
HU9402816D0 (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
ZA931700B (en) Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120719

Country of ref document: FI

MM Patent lapsed